Invention Grant
- Patent Title: Lactobacillus johnsonii La1 NCC533 (CNCM I-1225) and immune disorders
-
Application No.: US13319632Application Date: 2010-05-07
-
Publication No.: US10576110B2Publication Date: 2020-03-03
- Inventor: Valerie Petit , Clara Garcia-Rodenas , Monique Julita , Guenolee Prioult , Annick Mercenier , Sophie Nutten
- Applicant: Valerie Petit , Clara Garcia-Rodenas , Monique Julita , Guenolee Prioult , Annick Mercenier , Sophie Nutten
- Applicant Address: CH Vevey
- Assignee: Societe des Produits Nestle S.A.
- Current Assignee: Societe des Produits Nestle S.A.
- Current Assignee Address: CH Vevey
- Agency: K&L Gates LLP
- Priority: EP09159925 20090511; EP09159929 20090511
- International Application: PCT/EP2010/056295 WO 20100507
- International Announcement: WO2010/130662 WO 20101118
- Main IPC: A61K35/74
- IPC: A61K35/74 ; A61K35/745 ; A61K35/747 ; A23L33/00 ; A23L33/135 ; A23K10/18 ; A61K35/744 ; C12N1/20 ; C12N1/00 ; C12N1/36
Abstract:
The present invention generally relates to the field of preventing and/or treating inflammatory and infectious disorders, in particular by boosting the endogenous antimicrobial defences. One embodiment of the present invention is the use of non-replicating L. johnsonii La1 NCC533 (deposit number CNCM I-1225) for use in the treatment or prevention of disorders related to the immune system including infections.
Public/Granted literature
- US20130028877A1 LACTOBACILLUS JOHNSONII La1 NCC533 (CNCM I-1225) AND IMMUNE DISORDERS Public/Granted day:2013-01-31
Information query
